Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion

Published:2019-01-31 Issue:5 Volume:49 Page:594-599
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Takeda Haruhiko¹²,Nishijima Norihiro²,Nasu Akihiro²,Komekado Hideyuki²^ORCID,Kita Ryuichi²,Kimura Toru²,Kudo Masatoshi³,Osaki Yukio²

Affiliation:

1. Department of Gastroenterology and Hepatology, Graduate School of MedicineKyoto University Kyoto

2. Department of Gastroenterology and HepatologyOsaka Red Cross Hospital Osaka

3. Department of Gastroenterology and HepatologyKindai University Faculty of Medicine Osaka Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13294

Reference23 articles.

1. Hepatocellular carcinoma

2. Global cancer statistics, 2012

3. Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis

4. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

5. Sorafenib in Advanced Hepatocellular Carcinoma

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?;Liver Research;2024-09

2. Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities;Cancer Science;2024-05-02

3. CHOP regulated by METTL14-m6A affects cell cycle arrest and regorafenib sensitivity in HCC cells;BMC Cancer;2024-04-25

4. Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature;World Journal of Gastrointestinal Oncology;2024-04-15

5. Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives;Cancers;2024-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3